[A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. (NCI04) ( NCI )]
UMLS (NCI) C0338223 - Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor